This Article Full Text Full Text (PDF) Supplemental material Other Versions of this Article: MCB.00331-08v1 28/17/5147    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Google Scholar Articles by To, K. K. W. Articles by Bates, S. E. PubMed PubMed Citation Articles by To, K. K. W. Articles by Bates, S. E.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2008, p. 5147-5161, Vol. 28, No. 17
0270-7306/08/$08.00+0     doi:10.1128/MCB.00331-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line ^,

Molecular Therapeutics Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892,¹ Exiqon A/S, Bygstubben 9, DK-2950 Vedbœk, Denmark²

Received 27 February 2008/ Returned for modification 10 April 2008/ Accepted 11 June 2008

ABCG2 is recognized as an important efflux transporter in clinical pharmacology and is potentially important in resistance to chemotherapeutic drugs. To identify epigenetic mechanisms regulating ABCG2 mRNA expression at its 3' untranslated region (3'UTR), we performed 3' rapid amplification of cDNA ends with the S1 parental colon cancer cell line and its drug-resistant ABCG2-overexpressing counterpart. We found that the 3'UTR is >1,500 bp longer in parental cells and, using the miRBase TARGETs database, identified a putative microRNA (miRNA) binding site, distinct from the recently reported hsa-miR520h site, in the portion of the 3'UTR missing from ABCG2 mRNA in the resistant cells. We hypothesized that the binding of a putative miRNA at the 3'UTR of ABCG2 suppresses the expression of ABCG2. In resistant S1MI80 cells, the miRNA cannot bind to ABCG2 mRNA because of the shorter 3'UTR, and thus, mRNA degradation and/or repression on protein translation is relieved, contributing to overexpression of ABCG2. This hypothesis was rigorously tested by reporter gene assays, mutational analysis at the miRNA binding sites, and forced expression of miRNA inhibitors or mimics. The removal of this epigenetic regulation by miRNA could be involved in the overexpression of ABCG2 in drug-resistant cancer cells.

Published ahead of print on 23 June 2008.

Supplemental material for this article may be found at http://mcb.asm.org/.